Repligen Corp. buy Wolfe Research
Start price
29.04.25
/
50%
€123.75
Target price
29.04.26
€140.48
Performance (%)
-16.48%
Price
07.04.26
€99.46
Summary
This prediction is currently active. The prediction for Repligen Corp. disappoints with a performance of -16.48%. This prediction currently runs until 29.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Repligen Corp. | -2.538% | -2.538% |
| iShares Core DAX® | 4,24 % | 2,86 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % |
| iShares S&P 500 | 3,53 % | 1,95 % |
Comments by Wolfe_Research for this prediction
In the thread Repligen Corp. diskutieren
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat